| Ident. | Authors (with country if any) | Title |
|---|
| 000006 |
Martina Wollenhaupt [Suisse] ; Abhijeeth Chandrasekaran [Inde] ; Danitza Tomianovic [Suisse] | The safety of oseltamivir in pregnancy: an updated review of post-marketing data |
| 000115 |
Carol Yuet Sheung Yuen [Hong Kong] ; Marie Tarrant [Hong Kong] | Determinants of uptake of influenza vaccination among pregnant women - A systematic review |
| 000236 |
Kristofer Bandayrel [Canada] ; Stephen Lapinsky [Canada] ; Michael Christian [Canada] | Information Technology Systems for Critical Care Triage and Medical Response During an Influenza Pandemic: A Review of Current Systems |
| 000252 |
Stella G. Muthuri [Royaume-Uni] ; Puja R. Myles [Royaume-Uni] ; Sudhir Venkatesan [Royaume-Uni] ; Jo Leonardi-Bee [Royaume-Uni] ; Jonathan S. Nguyen-Van-Tam [Royaume-Uni] | Impact of Neuraminidase Inhibitor Treatment on Outcomes of Public Health Importance During the 2009-2010 Influenza A(H1N1) Pandemic: A Systematic Review and Meta-Analysis in Hospitalized Patients |
| 000290 |
Janna K. Breteler [Suisse, Pays-Bas] ; John S. Tam [Suisse] ; Mark Jit [Royaume-Uni] ; Johannes C. F. Ket [Pays-Bas] ; Michiel R. De Boer [Pays-Bas] | Efficacy and effectiveness of seasonal and pandemic A (H1N1) 2009 influenza vaccines in low and middle income countries: A systematic review and meta-analysis |
| 000311 |
Justin R. Ortiz [États-Unis] ; Kristina E. Rudd [États-Unis] ; Danielle V. Clark [États-Unis] ; Shevin T. Jacob [États-Unis] ; T. Eoin West [États-Unis] | Clinical Research During a Public Health Emergency: A Systematic Review of Severe Pandemic Influenza Management |
| 000322 |
Daniel S. Chertow [États-Unis] ; Matthew J. Memoli [États-Unis] | Bacterial Coinfection in Influenza: A Grand Rounds Review |
| 000361 |
| Vaccins grippaux H1N1v et narcolepsie: un lien à mieux cerner |
| 000362 |
Mélanie Moltenis [France] ; Marie-Blanche Valnet-Rabier [France] ; Joël Leroy [France] ; Jean-Pierre Kantelip [France] | Point sur les vaccinations à risque pendant la grossesse |
| 000392 |
Swati Kumar [États-Unis] ; Kelly J. Henrickson [États-Unis] | Update on Influenza Diagnostics: Lessons from the Novel H1N1 Influenza A Pandemic |
| 000397 |
Vincent C. C. Cheng [République populaire de Chine] ; Kelvin K. W. To [République populaire de Chine, Hong Kong] ; Herman Tse [République populaire de Chine, Hong Kong] ; Ivan F. N. Hung [Hong Kong, République populaire de Chine] ; Kwok-Yung Yuen [République populaire de Chine, Hong Kong] | Two Years after Pandemic Influenza A/2009/H1N1: What Have We Learned? |
| 000754 |
Greg L. Plosker [Nouvelle-Zélande] | A/H5N1 Prepandemic Influenza Vaccine (Whole Virion, Vero Cell-Derived, Inactivated) [Vepacel®] |
| 000838 |
Juine-Ruey Chen [Taïwan] ; CHE MA [Taïwan] ; Chi-Huey Wong [Taïwan] | Vaccine design of hemagglutinin glycoprotein against influenza |
| 000895 |
L. Bavagnoli [Italie] ; G. Maga [Italie] | The 2009 Influenza Pandemic: Promising Lessons For Antiviral Therapy For Future Outbreaks |
| 000933 |
Holly Seale [Royaume-Uni] ; C. Raina Macintyre [Royaume-Uni] | Seasonal influenza vaccination in Australian hospital health care workers: a review : Practical neurology: Part I: Blurred vision, eye pain |
| 000A24 |
M. E. Falagas [Grèce, États-Unis] ; P. K. Koletsi [Grèce] ; E. Baskouta [Grèce] ; P. I. Rafailidis [Grèce] ; G. Dimopoulos [Grèce] ; D. E. Karageorgopoulos [Grèce] | Pandemic A(H1N1) 2009 influenza: review of the Southern Hemisphere experience |
| 000A57 |
Pinki Surana [Royaume-Uni] ; SHAN TANG [Royaume-Uni] ; Marilyn Mcdougall [Royaume-Uni] ; Cheuk Yan William Tong [Royaume-Uni] ; Esse Menson [Royaume-Uni] ; Ming Lim [Royaume-Uni] | Neurological complications of pandemic influenza A H1N1 2009 infection: European case series and review |
| 000B25 |
Valentina Parodi [Italie] ; Daniela De Florentiis [Italie] ; Mariano Martini [Italie] ; Filippo Ansaldi [Italie] | Inactivated Influenza Vaccines: Recent Progress and Implications for the Elderly |
| 000B90 |
Alison Bish [Royaume-Uni] ; Lucy Yardley [Royaume-Uni] ; Angus Nicoll [Suède] ; Susan Michie [Royaume-Uni] | Factors associated with uptake of vaccination against pandemic influenza: A systematic review |
| 000D06 |
Thanyada Rungrotmongkol [Thaïlande] ; Pathumwadee Yotmanee [Thaïlande] ; Nadtanet Nunthaboot [Thaïlande] ; Supot Hannongbua [Thaïlande] | Computational Studies of Influenza A Virus at Three Important Targets: Hemagglutinin, Neuraminidase and M2 Protein |
| 000E21 |
Laura G. Mosby [États-Unis] ; Sonja A. Rasmussen [États-Unis] ; Denise J. Jamieson [États-Unis] | 2009 pandemic influenza A (H1 N1) in pregnancy: a systematic review of the literature |
| 000E88 |
F. Mahassin [France] ; S. Jaureguiberry [France] ; G. Monsel [France] ; E. Caumes [France] ; F. Bricaire [France] | Grippe A (H1N1) 2009. Revue générale |
| 000F42 |
Marc P. Girard [France] ; John S. Tam [Suisse] ; Olga M. Assossou [France] ; Marie Paule Kieny [Suisse] | The 2009 A (H1N1 ) influenza virus pandemic: A review |
| 000F43 |
Francesco Aimone [États-Unis] | The 1918 Influenza Epidemic in New York City: A Review of the Public Health Response |
| 000F79 |
Jean-Paul Selten [Pays-Bas] ; Aleida Frissen [Pays-Bas] ; Gerty Lensvelt-Mulders [Pays-Bas] ; Vera A. Morgan [Australie] | Schizophrenia and 1957 Pandemic of Influenza: Meta-analysis |
| 000F81 |
Elisa Prieto-Lara [Espagne] ; Aurora Llanos-Mendez [Espagne] | Safety and immunogenicity of prepandemic H5N1 influenza vaccines: A systematic review of the literature |
| 000F93 |
J.-F. Rahier [Belgique] ; Y. Yazdanpanah [France] ; N. Viget [France] ; S. Travisi [Royaume-Uni] ; J.-F. Colombel [France] | Review article: influenza A (H1 N1) virus in patients with inflammatory bowel disease |
| 001060 |
Jean Maritz [Afrique du Sud] ; Leana Maree [Afrique du Sud] ; Wolfgang Preiser [Afrique du Sud] | Pandemic influenza A (H1N1) 2009: the experience of the first six months |
| 001217 |
B. J. Cowling [Hong Kong] ; Y. Zhou [Hong Kong] ; D. K. M. Ip [Hong Kong] ; G. M. Leung [Hong Kong] ; A. E. Aiello [États-Unis] | Face masks to prevent transmission of influenza virus: a systematic review |
| 001222 |
Ed Delaney [États-Unis] ; Michael J. Smith [États-Unis] ; Brian T. Harvey [États-Unis] ; Keith J. Pelletier [États-Unis] ; Michael P. Aquino [États-Unis] ; Justin M. Stone [États-Unis] ; Gerald C. Jean-Baptiste [États-Unis] ; Julie H. Johnson [États-Unis] | Extracorporeal Life Support for Pandemic Influenza: The Role of Extracorporeal Membrane Oxygenation in Pandemic Management |
| 001264 |
David A. Boltz [États-Unis] ; Jerry R. Jr Aldridge [États-Unis] ; Robert G. Webster [États-Unis] ; Elena A. Govorkova [États-Unis] | Drugs in Development for Influenza |
| 001345 |
Michael J. Loeffelholz [États-Unis] | Avian Influenza A H5N1 Virus |
| 001437 |
Pierre Loulergue [France] ; Odile Launay [France] | Vaccins pandémiques et prépandémiques dirigés contre le virus grippal H5N1: État des lieux en 2009 |
| 001439 |
| Vaccin H1N1 pour prévenir la grippe pandémique |
| 001465 |
Wendy A. Keitel [États-Unis] ; Robert L. Atmar [États-Unis] | Vaccines for Pandemic Influenza: Summary of Recent Clinical Trials |
| 001473 |
Ioanna Skountzou [États-Unis] ; Sang-Moo Kang [États-Unis] | Transcutaneous Immunization with Influenza Vaccines |
| 001504 |
Kathryn M. Edwards [États-Unis] ; Adam Sabow [États-Unis] ; Andrew Pasternak [États-Unis] ; John W. Boslego [États-Unis] | Strategies for Broad Global Access to Pandemic Influenza Vaccines |
| 001514 |
Anthony E. Fiore [États-Unis] ; Carolyn B. Bridges [États-Unis] ; Nancy J. Cox [États-Unis] | Seasonal Influenza Vaccines |
| 001525 |
Terrence M. Tumpey [États-Unis] ; Jessica A. Belser [États-Unis] | Resurrected Pandemic Influenza Viruses |
| 001528 |
Sarah A. Kopecky-Bromberg [États-Unis] ; Peter Palese [États-Unis] | Recombinant Vectors as Influenza Vaccines |
| 001529 |
John Treanor [États-Unis] | Recombinant Proteins Produced in Insect Cells |
| 001541 |
Benjamin Schwartz [États-Unis] ; Walter A. Orenstein [États-Unis] | Prioritization of Pandemic Influenza Vaccine: Rationale and Strategy for Decision Making |
| 001556 |
Hui-Ling Yen [États-Unis] ; Robert G. Webster [États-Unis] | Pandemic Influenza as a Current Threat |
| 001562 |
Lauren J. Dimenna [États-Unis] ; Hildegund C. J. Ertl [États-Unis] | Pandemic Influenza Vaccines |
| 001584 |
Aeron C. Hurt [Australie] ; Jessica K. Holien [Australie] ; Michael W. Parker [Australie] ; Ian G. Barr [Australie] | Oseltamivir Resistance and the H274Y Neuraminidase Mutation in Seasonal, Pandemic and Highly Pathogenic Influenza Viruses |
| 001616 |
Grace L. Chen [États-Unis] ; Kanta Subbarao [États-Unis] | Live Attenuated Vaccines for Pandemic Influenza |
| 001631 |
Darrell R. Kapczynski [États-Unis] ; David E. Swayne [États-Unis] | Influenza Vaccines for Avian Species |
| 001639 |
Suryaprakash Sambhara [États-Unis] ; Janet E. Mcelhaney [Canada] | Immunosenescence and Influenza Vaccine Efficacy |
| 001665 |
Eduardo O'Neill [États-Unis] ; Ruben O. Donis [États-Unis] | Generation and Characterization of Candidate Vaccine Viruses for Prepandemic Influenza Vaccines |
| 001712 |
HUALAN CHEN [République populaire de Chine] ; ZHIGAO BU [République populaire de Chine] | Development and Application of Avian Influenza Vaccines in China |
| 001716 |
Taisuke Horimoto [Japon] ; Yoshihiro Kawaoka [Japon, États-Unis] | Designing Vaccines for Pandemic Influenza |
| 001719 |
JIN HYANG KIM [États-Unis] ; Joshy Jacob [États-Unis] | DNA Vaccines Against Influenza Viruses |
| 001725 |
Norman W. Baylor [États-Unis] ; Florence Houn [États-Unis] | Considerations for Licensure of Influenza Vaccines with Pandemic and Prepandemic Indications |
| 001746 |
J. P. Wong [Canada] ; M. E. Christopher [Canada] ; S. Viswanathan [Canada] ; X. Dai [Canada] ; A. M. Salazar [États-Unis] ; L.-Q. Sun [République populaire de Chine] ; M. Wang [République populaire de Chine] | Antiviral Role of Toll-Like Receptor-3 Agonists Against Seasonal and Avian Influenza Viruses |
| 001748 |
Adrianus C. M. Boon [États-Unis] ; Richard J. Webby [États-Unis] | Antigenic Cross-Reactivity Among H5N1 Viruses |
| 001750 |
Mark Von Itzstein [Australie] ; Robin Thomson [Australie] | Anti-Influenza Drugs : The Development of Sialidase Inhibitors |
| 001751 |
Ralph A. Tripp [États-Unis] ; S. Mark Tompkins [États-Unis] | Animal Models for Evaluation of Influenza Vaccines |
| 001756 |
Robert L. Atmar [États-Unis] ; Wendy A. Keitel | Adjuvants for Pandemic Influenza Vaccines |
| 001812 |
Patrick Goubau [Belgique] | LES MALADIES VIRALES ÉMERGENTES EN BELGIQUE ET AILLEURS |
| 001848 |
Gerardo Chowell [États-Unis] ; Hiroshi Nishiura [Pays-Bas] | Quantifying the transmission potential of pandemic influenza |
| 001880 |
Mary Jo Kasten [États-Unis] ; Gregory A. Poland [États-Unis] | Influenza Vaccination and the Elderly : Pandemic Preparedness |
| 001885 |
Mike Bray [États-Unis] | Highly pathogenic RNA viral infections; Challenges for antiviral research |
| 001926 |
Jennifer M. Audsley [Australie] ; Gregory A. Tannock [Australie] | Cell-Based Influenza Vaccines : Progress to Date |
| 001962 |
Pierre Gallois [France] ; Jean-Pierre Vallee [France] ; Yves Le Noc [France] | Tabagisme : de la dépendance au sevrage |
| 001973 |
H. Gras-Masse [France] ; N. Willand [France] | Glycochimie et thérapeutique Les inhibiteurs de neuraminidase face au risque de grippe aviaire |
| 001983 |
John Oxford [Royaume-Uni] ; Robert Lambkin-Williams ; Alex Mann | The threat of avian influenza H5N1 : 'do we have the tools for the job?' |
| 001A22 |
Tatiana Betakova [Slovaquie] | M2 protein : A proton channel of influenza A virus : Ion channels as a target for drug desing |
| 001B07 |
Didier Ingrand [France] | La grippe espagnole de 1918 : Une pandémie virale vite oubliée |
| 001B10 |
Francois Bricaire [France] ; Philippe Bossi [France] ; M. Pierre Pene ; M. Maurice Tubiana | Infections virales émergentes. Discussion : Les zoonoses, passé, présent et avenir |
| 001B64 |
B. Schwartz [États-Unis] ; P. Wortley [États-Unis] | Mass vaccination for annual and pandemic influenza |
| 001C13 |
Menno D. De Jong [Viêt Nam] ; TRAN TINH HIEN [Viêt Nam] | Avian influenza A (H5N1) |
| 001C55 |
| Les antiviraux dans la grippe : Un complément à la vaccination, dans certains cas |
| 001C64 |
Colin R. Parrish [États-Unis] ; Yoshihiro Kawaoka [États-Unis, Japon] | The origins of new pandemic viruses: The acquisition of new host ranges by canine parvovirus and influenza A viruses |
| 001C71 |
Edward W. A. Brydon [États-Unis] ; Susan J. Morris [Royaume-Uni] ; Clive Sweet [Royaume-Uni] | Role of apoptosis and cytokines in influenza virus morbidity |
| 001C83 |
F. O. Adungo [Kenya] ; N. I. Adungo [Kenya] ; S. Bedno [Kenya] ; S. L. Yingst [Égypte] | Influenza: the next pandemic? : A review |
| 001C85 |
N. Bardiya [Corée du Sud] ; J. H. Bae [Corée du Sud] | Influenza vaccines : recent advances in production technologies |
| 001C86 |
Kristin L. Nichol [États-Unis] | Influenza vaccination in the elderly : Impact on hospitalisation and mortality |
| 001D08 |
Marc P. Girard [France] ; Thomas Cherian [Suisse] ; Yuri Pervikov [Suisse] ; Marie Paule Kieny [Suisse] | A review of vaccine research and development : Human acute respiratory infections |
| 001D54 |
Arnold S. Monto [États-Unis] | The role of antivirals in the control of influenza |
| 001D65 |
Karl G. Nicholson [Royaume-Uni] ; John M. Wood [Royaume-Uni] ; Maria Zambon [Royaume-Uni] | Influenza |
| 001D79 |
R. Medeiros [France] ; N. Naffakh [France] ; J.-C. Manuguerra [France] ; S. Van Der Werf [France] | Structure et mécanismes de variation des virus grippaux |
| 001D89 |
Maurice R. Hilleman [États-Unis] | Realities and enigmas of human viral influenza: pathogenesis, epidemiology and control |
| 001D96 |
Yu. Z. Gendon | En Russe |
| 001E04 |
Ann H. Reid [États-Unis] ; Jeffery K. Taubenberger [États-Unis] ; Thomas G. Fanning [États-Unis] | The 1918 Spanish influenza : integrating history and biology |
| 001E10 |
I. Stephenson [Royaume-Uni] ; K. G. Nicholson [Royaume-Uni] | Influenza : vaccination and treatment |
| 001E22 |
E. C. J. Claas [Pays-Bas] | Pandemic influenza is a zoonosis, as it requires introduction of avian-like gene segments in the human population |
| 001E23 |
K. F. Shortridge [Hong Kong] ; PENG GAO [États-Unis] ; YI GUAN [États-Unis] ; T. Ito [Japon] ; Yoshihiro Kawaoka [États-Unis] ; D. Markwell [Hong Kong] ; A. Takada [Japon] ; R. G. Webster [États-Unis] | Interspecies transmission of influenza viruses: H5N1 virus and a Hong Kong SAR perspective |
| 001E24 |
M. Lüscher-Mattli [Suisse] | Influenza chemotherapy : a review of the present state of art and of new drugs in development: Brief Review |
| 001E29 |
G. Meulemans ; A. Burny ; G. Meulemans ; M. Parmentier ; J. Content ; J. Christophe ; C. Lapiere | Transmission inter-espèces du virus de la grippe |
| 001E48 |
A. W. Hampson [Australie] | Surveillance for pandemic influenza |
| 001E50 |
R. G. Webster [États-Unis] | Predictions for future human influenza pandemics |
| 001E54 |
R. G. Webster [États-Unis] ; K. F. Shortridge [Hong Kong] ; Yoshihiro Kawaoka [États-Unis] | Influenza : interspecies transmission and emergence of new pandemics |
| 001E55 |
R. B. Couch [États-Unis] ; W. A. Keitel ; T. R. Cate | Improvement of inactivated influenza virus vaccines |
| 001E56 |
F. G. Hayden [États-Unis] | Antivirals for pandemic influenza |
| 001E62 |
W. P. Glezen [États-Unis] | Emerging infections : Pandemic influenza |
| 001E65 |
C. Maillard | Grippe : la menace pandémique |
| 001E73 |
D. Shoham [Israël] | Biotic-abiotic mechanisms for long-term preservation and reemergence of influenza type A virus genes |
